CareMax Reports Fourth Quarter and Full Year 2023 Results
CareMax, Inc. - Class A (CMAX)
Company Research
Source: Business Wire
Met 2023 Guidance for Medicare Advantage Membership and Total RevenueYear-end 2023 Medicare Advantage Membership of 111,500, up 19% year-over-yearFull Year 2023 Total Revenue of $751.1 million, up 19% year-over-yearExploring Strategic Options to Maximize Value of Certain Assets and Generate Further Liquidity MIAMI--(BUSINESS WIRE)--CareMax, Inc. (NASDAQ: CMAX; CMAXW) (“CareMax” or the “Company”), a leading technology-enabled value-based care delivery system, today announced financial results for the fourth quarter and full year ended December 31, 2023.“In the fourth quarter, we began taking major steps with the goal of solidifying the long-term viability of our business,” said Carlos de Solo, Chief Executive Officer. “We have made difficult but necessary decisions to de-emphasize certain longer duration investments, such as de novo centers, and to refocus efforts on driving medical margin within our core centers and management services organization while implementing cost saving in
Show less
Read more
Impact Snapshot
Event Time:
CMAX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CMAX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CMAX alerts
High impacting CareMax, Inc. - Class A news events
Weekly update
A roundup of the hottest topics
CMAX
News
- CareMax, Inc. (NASDAQ: CMAX) had its price target lowered by analysts at UBS Group AG from $7.00 to $6.40. They now have a "neutral" rating on the stock.MarketBeat
- New Strong Sell Stocks for March 28th [Yahoo! Finance]Yahoo! Finance
- CareMax, Inc. (NASDAQ:CMAX) Q4 2023 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- Canopy Growth, Outlook Therapeutics, Immuneering among healthcare movers [Seeking Alpha]Seeking Alpha
- CareMax Reports Fourth Quarter and Full Year 2023 Results [Yahoo! Finance]Yahoo! Finance
CMAX
Earnings
- 3/18/24 - Miss
CMAX
Analyst Actions
- 4/1/24 - UBS
CMAX
Sec Filings
- 3/18/24 - Form 8-K
- 3/18/24 - Form NT
- 3/18/24 - Form 10-K
- CMAX's page on the SEC website